Skip to main content

Table 2 Comparison of IL28B genotype and allele between non-diabetic and diabetic

From: Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

Variable

Group I a & b

Non-diabetic (n = 80)

Group II a & b

Diabetic (n = 80)

Total

(n = 160)

χ2

p value

OR (95%CI)

Genotype

 

CC

29 (36.3%)

11 (13.7%)

40 (25%)

6.14

0.03*

1

CT

35 (43.7%)

47 (58.8%)

82 (51.3%)

3.01(1.31–6.88)

TT

16 (20.0%)

22 (27.5%)

38 (23.7%)

2.02(0.79–5.18)

Allele

 

C

94 (58.7%)

76 (47.5%)

85 (53.1%)

2.48

0.04*

1.45

(1.09–2.5)

T

66 (41.3%)

84 (52.5%)

75 (46.9%)

  1. X2 = Chi-square test *: significant p < 0.05 OR: odds ratio, CI: confidence interval